DELSTRIGO
doravirine, lamivudine, and tenofovir disoproxil fumarate
- Strength
- 100 mg/1, 300 mg/1, 300 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Merck Sharp & Dohme LLC
Not stocked by us — reference only
doravirine
Listed by Merck Sharp & Dohme LLC
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0006-3069 |
| FDA application | NDA210806 |
| RxNorm concept | 2055760 |
| Package sizes listed | 1 |
| Marketed since | July 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
doravirine, lamivudine, and tenofovir disoproxil fumarate
Merck Sharp & Dohme LLC
Not stocked by us — reference only
Doravirine, Islatravir
Merck Sharp & Dohme LLC
Not stocked by us — reference only
doravirine
A-S Medication Solutions
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.